Background Transient ischemic dilatation (TID) of the left ventricle is a potential marker of
high risk obstructive coronary artery disease on stress myocardial perfusion imaging (MPI) …

Myocardial perfusion imaging (MPI) is an established diagnostic test that provides useful
prognostic data in patients with known or suspected coronary artery disease. In more than …

Background The prognostic value of regadenoson SPECT myocardial perfusion imaging
(MPI) has not been specifically studied in patients with end-stage renal disease (ESRD) …

Abstracts Background An AHA/ACCF scientific statement proposed 8 risk factors to assess
the need for noninvasive coronary artery disease (CAD) surveillance in asymptomatic …

The central mission of the American Society of Nuclear Cardiology (ASNC) is to improve
cardiovascular outcomes through image-guided patient management. The most commonly …

Background Blunted heart rate response (HRR) to vasodilator stress agents is associated
with worse outcomes. There are limited data assessing the effect of impaired HRR to …

Abstract Purpose of Review Patients with end-stage renal disease (ESRD) have an
increased risk of cardiovascular morbidity and mortality. Cardiac risk assessment, though …

Background Upper reference limits for transient ischemic dilation (TID) have not been
rigorously established for cadmium-zinc-telluride (CZT) camera systems. We aimed to derive …

Background Transient ischemic dilation (TID) of the left ventricle seen on myocardial
perfusion imaging (MPI) is sometimes used as a marker of severe coronary artery disease …

Background There are limited data on the prognostic utility of regadenoson SPECT
myocardial perfusion imaging (MPI) in patients with end-stage renal disease (ESRD) …